Refocus Eye Health

The firm pursues a buy-and-build consolidation strategy in the ophthalmology and optometry sector. It acquires controlling interests in independent eye-care practices and ambulatory surgery centers, then centralizes administrative and operational functions to drive efficiency. The platform is built to scale both through organic growth at existing practices and through add-on acquisitions of additional clinics within targeted geographies.

The identity of the institutional sponsor or financial backers is not publicly disclosed. The firm's structure — a consolidation platform acquiring physician practices — is consistent with a private equity-backed model, but no named sponsor appears in available public records or the firm's own limited public communications as of 2026.

Refocus Eye Health targets established ophthalmology and optometry groups with strong local patient volumes and a reputation for clinical quality. The firm's interests span medical and surgical ophthalmology, routine optometry, and co-located optical retail. Practices that include or can support an ambulatory surgery center are a particular focus, given their higher-margin procedural mix.

The firm is headquartered in Rye Brook, New York, and its clinical network extends across multiple US states. Without a public directory of affiliated practices, the precise geographic footprint is not fully verifiable. The consolidation thesis typically involves regional clustering, so the platform likely operates in concentrated hubs in the Northeast or other demographically favorable markets.

Physician founders typically sell a majority equity stake to the platform while retaining meaningful minority ownership and continuing to lead their practices clinically. This aligns long-term incentives and gives the founding doctors a second liquidity event when the platform eventually realizes its investment. The firm provides centralized non-clinical management, allowing doctors to focus on patient care and practice growth.